Kevin M. Lalande insider trades: Molecular Templates (MTEM) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Kevin reports to the SEC
Open-market buys and sales
13 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 15, 2022 | MTEM | ↑ Buy | 222,000 | $0.89 | $198K | By SHVMS, LLC | Jun 21, 2022 (6d) |
| Sep 8, 2021 | (LUMO) | ↑ Buy | 10,000 | $11.21 | $112K | By Sante Health Ventures II, LP | Sep 10, 2021 (2d) |
| Sep 7, 2021 | (LUMO) | ↑ Buy | 24,400 | $11.22 | $274K | By Sante Health Ventures II, LP | Sep 7, 2021 (0d) |
| Sep 1, 2021 | (LUMO) | ↑ Buy | 19,214 | $10.66 | $205K | By Sante Health Ventures II, LP | Sep 1, 2021 (0d) |
| Aug 27, 2021 | (LUMO) | ↑ Buy | 26,081 | $10.04 | $262K | By Sante Health Ventures II, LP | Aug 27, 2021 (0d) |
| Aug 24, 2021 | (LUMO) | ↑ Buy | 84,254 | $9.21 | $776K | By Sante Health Ventures II, LP | Aug 24, 2021 (0d) |
| Aug 19, 2021 | (LUMO) | ↑ Buy | 64,870 | $8.58 | $556K | By Sante Health Ventures II, LP | Aug 19, 2021 (0d) |
| Aug 16, 2021 | (LUMO) | ↑ Buy | 93,000 | $7.79 | $724K | By Sante Health Ventures II, LP | Aug 16, 2021 (0d) |
| Sep 16, 2020 | MTEM | ↓ Sell | 500,000 | $13.05 | $6.5M | Held by Sante Health Ventures I, L.P. | Sep 18, 2020 (2d) |
| May 20, 2020 | MTEM | ↓ Sell | 300,000 | $16.51 | $5.0M | Held by Sante Health Ventures I, L.P. | May 22, 2020 (2d) |
| Jun 10, 2015 | LDRH | ↓ Sell | 834 | $44.77 | $37K | Direct | Jun 12, 2015 (2d) |
| Mar 2, 2015 | LDRH | ↓ Sell | 5,000 | $38.50 | $192K | By:Lalorne Mgt Trust | Mar 4, 2015 (2d) |
| Mar 2, 2015 | LDRH | ↓ Sell | 1,099 | $38.50 | $42K | By: Family Trust | Mar 4, 2015 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Kevin M. Lalande's insider trades
Kevin M. Lalande is an insider at Molecular Templates (MTEM). Since Mar 2, 2015, Kevin has reported 8 open-market purchases worth $3.1M and 5 sales worth $11.8M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (20 filings), option exercises (4 filings), other transactions (3 filings), shares returned to the company (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MTEM insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.